10:40 AM EDT, 03/31/2025 (MT Newswires) -- D-Wave Quantum ( QBTS ) and the pharmaceutical division of Japan Tobacco said Monday that they completed a joint proof-of-concept project adapting D-Wave's quantum computing technology and artificial intelligence for the drug discovery process.

The companies developed hybrid large language models that generated "more valid" molecules with a higher quantitative estimate of drug-likeness, compared with classical methods alone, they said.

Following the proof-of-concept project, Japan Tobacco's pharmaceutical division now plans to further advance development of quantum AI-driven drug discovery technology for molecular design, the companies said.

Price: 7.59, Change: +0.01, Percent Change: +0.15